A Turning Point in Organizational Governance: JCI's Medical AI Guidelines

In June 2026, the Joint Commission (JCI), in collaboration with the Coalition for Health AI (CHAI), officially launched the “Responsible Use of AI in Healthcare” (RUAIH) certification standards. Known as the gold standard in international hospital management, JCI has drawn attention with this first systematic framework defining the responsible use of AI in healthcare institutions.

At the core of the RUAIH certification is not the performance of technological algorithms but the maturity of governance systems within healthcare organizations. The certification evaluates not the AI systems themselves but the organization’s capacity to responsibly manage and operate them.

Governance Based on Seven Pillars

The RUAIH certification breaks down the responsible use of AI into seven management dimensions.

The first is “Policies and Organizational Governance Structure.” Hospitals are required to establish an interdisciplinary AI governance committee led by senior management. This committee must create policies covering the entire lifecycle of AI, from procurement to risk mitigation. The governance team should include representatives from hospital administration, quality management, IT, ethics committees, and heads of major clinical departments.

The second dimension is “Patient Privacy and Transparency.” Hospitals must adequately disclose to patients and their families whenever AI tools significantly influence diagnosis or treatment plans. Clinicians must be able to explain the rationale behind AI recommendations in plain language.

The third pillar is “Data Security and Usage Protection.” Before clinical data is incorporated into external AI models, strict anonymization protocols must be implemented. Data utilization agreements (DUAs) are mandatory to prevent suppliers from using hospital data for training commercial models.

The fourth is “Continuous Quality Monitoring.” Given the ever-changing nature of real-world clinical environments, AI systems are prone to algorithmic drift. Hospitals should conduct regular backend monitoring and random audits, promptly adjusting or suspending use if accuracy declines.

The fifth dimension concerns “Risk and Bias Assessment.” Before full-scale implementation, hospitals must conduct local baseline validation using their past year’s cases to assess for systematic biases affecting specific age groups, genders, or populations with complex underlying conditions.

The sixth pillar is “Blind Safety Incident Reporting.” Hospitals are required to establish a non-punitive mechanism for reporting adverse events, ensuring no concealment of AI-related medical errors. Reported incidents should be anonymized and shared with third parties to manage risks effectively.

The seventh and final dimension is “Safety Culture and Human Resource Development.” Training programs should emphasize the scope of AI applications while clearly defining that ultimate clinical decisions rest with physicians. Systems must be designed to prevent over-reliance on AI, which can erode the expertise of junior doctors.

Implications for Domestic Hospital Management

Currently, many healthcare institutions allow IT departments to lead the adoption of AI, focusing primarily on technical metrics. The RUAIH standards emphasize the importance of governance structures at the organizational level. Hospitals need to establish AI clinical governance committees, led by a vice president of operations, centered on medical quality management and supported by IT departments.

Of particular note is the principle that clinical systems must not connect to AI until local validation and algorithm bias reviews are complete. This stems from viewing AI not as mere software but as a “virtual clinical workforce” with autonomous decision-making potential.

Mitigating Clinical AI Risks

RUAIH identifies physician over-reliance on AI as a critical risk. To counter this, the standards mandate the integration of human decision-making checkpoints into system design. For example, AI recommendations should only be accessible after a physician has made a preliminary assessment.

The guidelines also call for the inclusion of training on identifying incorrect AI outputs and emphasize the need for a system where humans retain the final authority to overrule AI decisions. Establishing a mechanism to report and analyze AI-related adverse events must become part of the organizational safety culture.

The Importance of Data Governance

Regarding data protection, RUAIH underscores the concept of hospital data sovereignty. To prevent technology companies from freely acquiring patient data for commercial model development, strict data utilization agreements and anonymized discharge auditing systems must be in place. Hospitals, as data custodians, must ensure that suppliers use acquired data exclusively to enhance the quality of their medical services.

Many current medical AI projects proceed with ambiguous data usage conditions. RUAIH sets a clear warning against such practices and establishes a new standard for data governance.

Applicability to Hospital Accreditation

In domestic hospital accreditation systems, the introduction of “AI Clinical Governance Maturity” as an evaluation criterion is gaining attention. Adding evaluation points, such as algorithm drift monitoring, AI adverse event reporting, and training records, could guide AI applications toward safer and more responsible usage.

Although JCI’s activities are currently limited outside China, its research outcomes and standards remain valuable references for international healthcare management frameworks. RUAIH, in particular, could serve as a roadmap for advanced healthcare institutions aiming to maintain high-quality care through AI adoption.

Editorial Opinion

In the short term, as RUAIH gains international recognition, Japanese healthcare institutions are expected to accelerate the review of their governance systems for AI adoption. University hospitals and large medical centers, in particular, may establish AI governance committees and revise data utilization agreements between late 2026 and 2027. This could usher in a critical period to balance the speed of technological adoption with safety.

From a long-term perspective, the framework set by RUAIH has the potential to become a model for AI governance not only in healthcare but also in other professional sectors like finance and law. Viewing AI as a “virtual workforce” rather than mere software could fundamentally transform organizational responsibility and human resource development. Over the next one to three years, cross-industry discussions on standardized AI governance are likely to gain momentum.

The editorial team is concerned, however, that the high standards set by RUAIH may pose significant challenges for small- to medium-sized healthcare institutions. Establishing governance structures inevitably requires human resources and costs, raising the need for phased application standards tailored to the scale of each healthcare institution.

References

• Huxiu — Published June 18, 2026
• Official JCI Website (The Joint Commission) — Official information on RUAIH certification standards
• CHAI (Coalition for Health AI) Official Website — Overview of their activities